Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-18

FDA Approved: INVEGA HAFYERA — Original Application (Janssen Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved INVEGA HAFYERA (paliperidone palmitate) from Janssen Pharmaceuticals in an Original Application. It is a long-acting injectable antipsychotic indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVEGA HAFYERA (PALIPERIDONE PALMITATE)

Snippet

ORIG AP for INVEGA HAFYERA (PALIPERIDONE PALMITATE)